-Mark Clemons Researcher Activity Profile

Research Author Detailed Information 

Mark Clemons Publication Rate By Year

Mark Clemons has published 5 paper(s) in 2007, 4 paper(s) in 2008, for a total of 9 research publications in total.

Mark M Clemons Author Information

LAST NAME: clemons

FIRST NAME: mark

INITIALS: M

AFFILIATION:

Papers

Mark Clemons's Publication Record

1. Identifying menopause in breast cancer patients: considerations and implications. Year Published: 2007
Division of Medical Oncology/Haematology, Princess Margaret Hospital, Suite 5-205, 610 University Avenue, M5G 2M9 Toronto, ON, Canada. Mark.Clemons@uhn.on.ca
2. First-line treatment options for patients with HER-2 negative metastatic breast cancer: the impact of modern adjuvant chemotherapy. Year Published: 2007
Division of Medical Oncology, Sunnybrook and Women's College Health Sciences Centre, T-Wing, 2nd Floor, TSRCC, Toronto, ON, Canada. sunil.verma@sunnybrook.ca
3. Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study. Year Published: 2007
Toronto Sunnybrook Regional Cancer Centre and Princess Margaret Hospital, Toronto, Canada.
4. Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study. Year Published: 2007
Toronto Sunnybrook Regional Cancer Centre and Princess Margaret Hospital, Toronto, Canada.
5. A Phase 2 study of perifosine in advanced or metastatic breast cancer. Year Published: 2008
Medical Oncology, Princess Margaret Hospital/University Health Network, 5-105 610 University Avenue, Toronto, ON, Canada, M5G 2M9, Natasha.Leighl@uhn.on.ca.
6. A phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy. Year Published: 2008
Division of Medical Oncology, Princess Margaret Hospital, 610 University Avenue Suite 5-205, Toronto, ON, Canada, M5G 2M9, mark.clemons@uhn.on.ca.
7. First-line treatment options for patients with HER-2 negative metastatic breast cancer: the impact of modern adjuvant chemotherapy. Year Published: 2007
Division of Medical Oncology, Sunnybrook and Women's College Health Sciences Centre, T-Wing, 2nd Floor, TSRCC, Toronto, ON, Canada. sunil.verma@sunnybrook.ca
8. Should urogenital atrophy in breast cancer survivors be treated with topical estrogens? Year Published: 2008
Princess Margaret Hospital, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada. mark.clemons@uhn.on.ca.
9. Pharmacotherapy of bone metastases in breast cancer patients. Year Published: 2008
Resident, Internal Medicine University of Toronto, Department of Medicine, 190 Elizabeth Street, Toronto, Ontario, M5G2C4, Canada.